Youmagic Developer Weimai Medical Secures Strategic Investment from Hengdian Capital, Keytone Capital Serves as Exclusive Financial Advisor

VCBeat has learned that WEMT, the developer of YOUMAGIC, has completed multiple rounds of financing in the past three months, with WinX Capital continuing to serve as the exclusive financial advisor. After announcing the completion of its Series B round, which secured over RMB 100 million from a leading domestic fund, in late 2024, and closing its Series B+ round, raising tens of millions of yuan from Xichuangtou and Suzhou Jinsheng Capital in February 2025, WEMT has once again secured strategic investment amounting to tens of millions of yuan from renowned industrial investor Hengdian Capital within a short period.

As the sole strategic and industrial investment platform of Hengdian Group, Hengdian Capital’s investment will help WEMT and its core product, YOUMAGIC high-energy monopolar radiofrequency, accelerateAccelerate the innovative R&D process in the field of energy medicine, speed up mass production and delivery of products, and advance commercialization layout.

Industrial Capital and Technology Resonate in Sync: YOUMAGIC Forges Ahead with Innovative Strength.

Hengdian Capital empowers high-quality enterprises through capital investment, with WEMT, the developer of YOUMAGIC, demonstrating broad development prospects as an emerging force in the industry. Hengdian Capital has long focused on investments in healthcare and related fields, leveraging industrial resources from its group companies, such as Apeloa Pharmaceutical and Weidu Medical, to conduct in-depth research and strategic investments in innovative drugs and medical devices.WEMT, the developer of YOUMAGIC, has been deeply engaged in the medical device industry for many years, fully promoting the localization of high-end medical devices through innovation, with a development direction aligned with that of Hengdian Group.This investment in WEMT has enriched Hengdian Capital’s investment portfolio and strategic layout, further perfecting the company’s ecosystem in the healthcare sector.

As Zhang Quanling, Founding Partner of Ziniu Fund, another investor in WEMT, stated, truly valuable and innovative medical projects must possess absolute technological leadership, target genuine market needs and policy windows, and be backed by a resilient team. The market calls for individuals with scientific competence, a scientific spirit, and entrepreneurial drive who are willing to navigate the challenging path of commercializing scientific and technological achievements; only with such dedication, coupled with capital and other resource investments, can success be achieved. WEMT precisely embodies these qualities, which has been key to securing its Series B+ financing co-led by Xichuangtou and Suzhou Jinsheng Capital, as well as the recent strategic investment from Hengdian Capital.

Currently,WEMT, the developer of YOUMAGIC, is continuously strengthening its R&D capabilities and exploring cutting-edge technologies. Meanwhile, its management team consistently demonstrates entrepreneurial spirit, targeting market demands to build competitive products and brands.As a technology transfer enterprise of Tsinghua University, WEMT has achieved efficient commercialization of scientific and technological achievements by leveraging the university’s extensive expertise in energy-based technologies. Its product portfolio, centered on energy-based technologies, is widely deployed across both serious medical care and consumer healthcare sectors, establishing a strong reputation and solid market foundation through robust technical capabilities and superior user experiences.

YOUMAGIC’s high-energy monopolar radiofrequency technology features a proprietary 100-millisecond flash pulse technique that overcomes the bottlenecks of conventional RF systems. By delivering denser pulses and nearly doubling the number of temperature monitoring points compared to traditional RF technologies, it enables stable thermal control of the skin during treatment, significantly enhancing both patient comfort and safety.YOUMAGIC also offers advantages such as ease of operation, safety and precision, and no need for topical anesthesia. It provides users with a better experience without compromising medical efficacy. The product has obtained the NMPA Class III medical device certification, and its market share is steadily increasing.

With the implementation of this strategic investment, WEMT, the R&D company behind YOUMAGIC, will leverage the financial and industrial resource advantages of investors such as Hengdian Capital.Accelerate mass production, delivery, and commercial deployment of products, while strengthening coordinated industrial development. The Company will continue to adhere to its development path integrating medicine and engineering, drive continuous innovation and breakthroughs, and develop more high-quality products.

The lead investor in the Series B+ round, Xi Chuangtou, stated:As the first innovative enterprise in China to obtain Class III medical device certification for Thermage, we highly recognize WEMT’s breakthrough achievements in integrating medicine and engineering within the field of precise energy-based technologies. We look forward to its role as an innovation engine for Wuxi’s medical aesthetics industry, reshaping the industry landscape through compliance and accelerating the global expansion of high-end, Chinese-made medical aesthetic devices.

Strategic investor Hengdian Capital stated:Following this strategic investment, Hengdian Capital will leverage its robust financial strength to accelerate WEMT’s innovation and commercialization of YOUMAGIC, while deeply integrating resources to comprehensively advance the market deployment of WEMT’s products and further increase market share. Furthermore, it will fully utilize its industrial advantages in basic scientific research, industry chain development, marketing models, and sales channels to drive leapfrog development for WEMT and its core product, YOUMAGIC High-Energy Monopolar Radiofrequency, from multiple dimensions. On one hand, by relying on Hengdian Group’s extensive industrial layout in the pharmaceutical and high-end medical aesthetics sectors, as well as its abundant hospital resources and channels, broad and high-quality industry resources will be provided to WEMT and YOUMAGIC High-Energy Monopolar Radiofrequency. This will facilitate efficient access to key sales channels such as hospitals, thereby expanding the scope for product promotion. On the other hand, the strategic capital injection from Hengdian Capital will provide strong financial support for WEMT, further expanding its R&D and technical advantages in the field of energy-based medicine, enhancing product competitiveness, and meeting the growing demands of the market.

Zhao Qian'ao, Head of Consumer Healthcare & Interdisciplinary Initiatives at WinX Capital, stated:Congratulations once again to WEMT for securing consecutive rounds of financing in a short period. Following the approval of its Class III medical device certification for YOUMAGIC at the end of last year, market promotion is currently in full swing. At this pivotal juncture, the support from shareholders such as Xi Venture Capital and Hengdian Capital will further consolidate industrial resources from all parties, paving the way for future market explosion. WinX Capital is honored to serve as the long-term exclusive financial advisor, continuously contributing to WEMT’s capital journey.